On Friday, LifeStance Health Group Inc (NASDAQ: LFST) was 3.84% up from the session before settling in for the closing price of $7.55. A 52-week range for LFST has been $4.64 – $9.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 51.51% over the past five years. When this article was written, the company’s average yearly earnings per share was at 66.28%. With a float of $111.01 million, this company’s outstanding shares have now reached $382.64 million.
Let’s look at the performance matrix of the company that is accounted for 9325 employees. In terms of profitability, gross margin is 25.94%, operating margin of -5.26%, and the pretax margin is -7.22%.
LifeStance Health Group Inc (LFST) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward LifeStance Health Group Inc stocks. The insider ownership of LifeStance Health Group Inc is 70.99%, while institutional ownership is 33.22%. The most recent insider transaction that took place on Nov 27 ’24, was worth 565,500. In this transaction Director of this company sold 75,000 shares at a rate of $7.54, taking the stock ownership to the 1,424,447 shares. Before that another transaction happened on Nov 27 ’24, when Company’s Director proposed sale 75,000 for $7.54, making the entire transaction worth $565,646.
LifeStance Health Group Inc (LFST) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 66.28% per share during the next fiscal year.
LifeStance Health Group Inc (NASDAQ: LFST) Trading Performance Indicators
You can see what LifeStance Health Group Inc (LFST) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 1.32. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.58. Likewise, its price to free cash flow for the trailing twelve months is 88.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.25, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.14 in one year’s time.
Technical Analysis of LifeStance Health Group Inc (LFST)
LifeStance Health Group Inc (NASDAQ: LFST) saw its 5-day average volume 1.17 million, a negative change from its year-to-date volume of 1.32 million. As of the previous 9 days, the stock’s Stochastic %D was 87.96%. Additionally, its Average True Range was 0.28.
During the past 100 days, LifeStance Health Group Inc’s (LFST) raw stochastic average was set at 75.24%, which indicates a significant decrease from 97.88% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.25% in the past 14 days, which was higher than the 37.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.25, while its 200-day Moving Average is $6.41. Nevertheless, the first resistance level for the watch stands at $7.93 in the near term. At $8.01, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.17. If the price goes on to break the first support level at $7.69, it is likely to go to the next support level at $7.53. Assuming the price breaks the second support level, the third support level stands at $7.45.
LifeStance Health Group Inc (NASDAQ: LFST) Key Stats
There are 382,640K outstanding shares of the company, which has a market capitalization of 3.12 billion. As of now, sales total 1,056 M while income totals -186,260 K. Its latest quarter income was 312,720 K while its last quarter net income were -5,960 K.
